Adaptive evaluation of mHealth and conventional adherence support interventions to optimize outcomes with new treatment regimens for drug-resistant tuberculosis and HIV in South Africa (ADAP-TIV): Study protocol for an adaptive randomized controlled trial

Mostrar otras versiones (1)

BACKGROUND: Highly effective, short course, bedaquiline-containing treatment regimens for multidrug-resistant tuberculosis (MDR-TB) and integrase strand transfer inhibitor (INSTI)-containing fixed dose combination antiretroviral therapy (ART) have radically transformed treatment for MDR-TB and HIV....

Descripción completa

Detalles Bibliográficos
Autores principales: Ross, Jesse E, Perumal, Rubeshan, Wolf, Allison, Zulu, Mbali, Guzman, Kevin, Seepamore, Boitumelo, Reis, Karl, Nyilana, Hlengiwe, Hlathi, Senzo, Narasimmulu, Radhamoney, Cheung, Ying Keun K, Amico, K Rivet, Friedland, Gerald, Daftary, Amrita, Zelnick, Jennifer, Naidoo, Kogieleum, O’Donnell, Max R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10274958/
https://www.ncbi.nlm.nih.gov/pubmed/37333087
http://dx.doi.org/10.21203/rs.3.rs-2841179/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10274958/
https://www.ncbi.nlm.nih.gov/pubmed/37333087
http://dx.doi.org/10.21203/rs.3.rs-2841179/v1

Ejemplares similares